Premature Ejaculation Cure: This Wearable Device Does It With Mild Electric Shocks Down There
Premature Ejaculation or PE is a problem that many men today face, but only a few truly know what¡¯s going on and are willing to fix it. However Morari Medical has a wearable device that can help men solve this embarrassing problem for them, at this year¡¯s CES.
Premature Ejaculation or PE is a problem that more than 30 percent men today face, but only a few truly know what¡¯s going on and are willing to fix it. However Morari Medical has a wearable device that can help men solve this embarrassing problem for them, at this year¡¯s CES.
CES is home to all kinds of cool innovation in commercial tech. However, this year CES also permitted sex tech companies to showcase their creation this year, as a trial. This gave access to various other sex-tech brands to show their innovation to the world, away from the lens of a taboo.
The technology at play here is neuromodulation. Basically, the device is placed right at the perineum -- the region between the anus and the scrotum -- with the help of adhesive and sits like a band-aid.
The tiny device has a small battery, electrodes and a Bluetooth receiver. It uses a technique that is applied to relieve pain by sending mild electrical pulses. The electrical pulses confuse the nerves that eventually helps in delaying the ejaculation. It basically uses transdermal electric neuromodulation -- commonly referred to as TENS to delay the process.
Bennett, founder of Morari Medical says in a statement, "PE is the number one male sexual dysfunction, yet most men don't want to talk about it. The use of neuromodulation is a common modality that has been proven to treat a variety of different medical conditions. Our product will employ neuromodulation and is intended to be easy-to-use, discreet, and won't interfere with the partner's enjoyment."
This product might seem game-changing, but it is still far from hitting the shelves. Morari Medical, along with San Diego Sexual Medicine, will first be conducting a study to test the product in the first quarter of 2020. Results of this study will help guide the company to a commercial release of a product which is presumed to be sometime next year.